F&P issues half, full-year 2025 guidance
By HME News Staff
Updated 9:15 AM CDT, Tue August 27, 2024
.jpg)
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has released guidance of revenue in the range of approximately $940 million to $950 million for the first half of its 2025 financial year, which ends Sept. 30, 2024. Full 2025 financial year guidance is expected to be in the range of approximately $1.9 billion to $2.0 billion, with full year net profit after tax to be in the range of approximately $320 million to $370 million. “The year to date has begun strongly across all products and regions,” said Lewis Gradon, managing director and CEO. “In the hospital product group, contributions include ongoing change in clinical practice, and a good response to new product introductions. In addition, early indications are that the year to date includes a relatively high hospital census during the period in both the Northern and Southern Hemispheres as Northern Hemisphere seasonal hospitalizations persisted into the beginning of this current financial year and hospitals have returned to more normalized staffing and capacity.”
Comments